Bioactive Molecules: Structures, Functions and Potential Uses for Cancer Prevention and Targeted Therapies (Volume II)

Dear Colleagues,

Cancer is a prevailing disease worldwide and is becoming worse as time goes on. Although some advanced, effective cancer therapies have been developed, there are limitations in current treatments, including severe side effects for patients, tumor recurrence and metastasis, and the development of drug resistance. Therefore, identifying novel cancer-specific targets and developing more effective, less toxic therapeutics is of urgent clinical significance to improve the survival rate of cancer patients.

Bioactive molecules play an important role in regulating the processes of cancer cell growth and development. The bioactive molecules interested in this Special Issue include small chemical molecules from nature and biomolecules found in living organisms, as well as their synthetic family members. It is well known that many clinically used drugs are developed from plants; many nutrient molecules from functional foods have cancer-preventive and antitumor activities; and many biomolecules (such as proteins and nucleic acids) are anticancer drug targets or have tumor-suppressing activities. All of these findings have been or could be used to develop new strategies for preventing and treating various cancers.

Our previous Special Issue has been very successful. Based on that, we would like to develop “Bioactive Molecules: Structures, Functions, and Potential Uses for Cancer Prevention and Targeted Therapies (Volume II),” which is to continuously publish selected review and research papers detailing bioactive molecules, their chemical structures, biological functions, cellular targets, signaling pathways, and mechanisms of action, as well as their potentials for cancer prevention, therapies, and management. We encourage you to submit manuscripts that fit the objectives and topics of this Special Issue.

Prof. Dr. Qingping Dou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• small molecules
• biomolecules
• molecular targeting
• natural products
• cancer management

• Bioactive Molecules: Structures, Functions, and Potential Uses for Cancer Prevention and Targeted Therapies in Biomolecules (8 articles)